Since our previous results suggest that urine NGAL is a good diagnostic marker of AKI in the early phase of AP [37], we may hypothesize that the simultaneous use of KeGFR with urine NGAL (or alternatively, other tubular markers) could be a sensitive diagnostic strategy for renal injury and dysfunction. Here, LCN2 is linked to alkaline phosphatase measurement.